Drostanolone (Propionate)

Drug #269

Drostanolone (Propionate) was formerly used in treatment of advanced breast cancer in post-menopausal females.

Primary Characteristics

It is of Synthetic origin and belongs to Steroid.

It belongs to Aldosterone agonist pharmacological group on the basis of mechanism of action and also classified in Anabolic Steroid pharmacological group. It is also classified under Hormones .

Molecular Weight: 360.5 · pK_a: not relevant · Solubility in Water: almost insoluble · Solubility in Alcohol: 1 in 30 · Non-proprietary name: Drostanolone (Propionate).

Molecular structure of Drostanolone (Propionate)

Pharmacokinetics

None recorded.

Indications

Drostanolone (Propionate) is primarily indicated in conditions like Metastatic carcinoma of breast.

Contraindications

Drostanolone (Propionate) is contraindicated in conditions like Hepatic disease, Carcinoma of male breast, Cardiac disease, Prostate cancer.

Dosage

Drostanolone (Propionate)'s dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
1.429 mg/kg	1.429 mg/kg	—	IM	Thrice a Week
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Drostanolone (Propionate) in overdosage may give rise to further complications which include Hoarseness , Deepening of voice .

Drostanolone (Propionate) is known to cause more or less tolerable side effects which are usually transient. These include Acne, Clitoromegaly , Coarser skin, Facial hair, Virilization.

Warnings / Precautions

Patients should be instructed to report any of the following: nausea, vomiting, changes in skin color, and ankle swelling. Males should be instructed to report too frequent or persistent erections of the penis and females any hoarseness, acne, changes in menstrual periods or increase in facial hair.

Available Brands

None recorded.

Storage Conditions

Drostanolone (Propionate) should be stored .

Drug Classification

1.18.11 — Anabolic drugs